Subscribe To

Price Alert Latest News Economic Calendar News

MLSS / Milestone Scientific Inc. (MLSS) Q2 2023 Earnings Call Transcript

Milestone Scientific Inc. (NYSE:MLSS ) Q2 2023 Earnings Conference Call August 15, 2023 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Peter Milligan - Chief Financial Officer Conference Call Participants Anthony Vendetti - Maxim Group Tucker Andersen - Above All Advisors Operator Greetings, and welcome to the Milestone Scientific Second Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. Read More

Demo Live Account See Partner Details

Content Topics

Milestone

Scientific

Inc

MLSS

2023

Earnings

Call

mlss

Transcript

Stock

Posted: Aug 15 2023, 12:41

Author Name: Seeking Alpha

MLSS News

By Seeking Alpha
August 15, 2023

Milestone Scientific Inc. (MLSS) Q2 2023 Earnings Call Transcript

Milestone Scientific Inc. (NYSE:MLSS ) Q2 2023 Earnings Conference Call August 15, 2023 8:30 AM ET Company Participants David Waldman - Investor Relat

By Seeking Alpha
June 15, 2023

Milestone Scientific: Buy For The $4 Billion Total Addressable Market

Milestone Scientific offers an innovative product line in the medical and dental segments, including a trademarked solution for Dentists to administer

By GlobeNewsWire
June 15, 2023

Milestone Scientific to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20th

ROSELAND, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems tha

By Seeking Alpha
June 10, 2023

Milestone Scientific: Sales Could Start To Snowball

The shift to online sales in their dental business produced unexpectedly fast results with revenue and gross margin up sharply and more to come. Most

By Seeking Alpha
March 31, 2023

Milestone Scientific Inc. (MLSS) Q4 2022 Earnings Call Transcript

Milestone Scientific Inc. (NYSE:MLSS ) Q4 2022 Results Conference Call March 31, 2023 8:30 AM ET Company Participants David Waldman - Investor Relatio

By Seeking Alpha
April 19, 2022

Milestone Scientific Is Attractive Here

A new focus on their Dental business and the easing of the pandemic produced a strong recovery which has legs. The growth of the installed base of dev

By Proactive Investors
April 11, 2022

Milestone Scientific begins sales of its CompuFlo Epidural and CathCheck Verification System disposables to premier US hospital

Milestone Scientific Inc (NYSE:MLSS), the medtech group, revealed that it has begun selling its CompuFlo Epidural and CathCheck Verification System di

By Benzinga
April 4, 2022

Here's Why Maxim Reduced Price Target On Milestone Scientific

Maxim has lowered the price target on Milestone Scientific Inc (NYSE: MLSS) to $4 from $6 but maintained a Buy rating on the shares. Analyst An

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.